Reprogramming Human Regulatory T cell Specificity

Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donor-derived human leukocyte antigen (HLA) is a promising strategy to induce immune tolerance to pancreatic islet transplants.